Skip to content
lifestyle.entreprenerd.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
AMGEN
/C O R R E C T I O N — Amgen/
April 30, 2026
AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
April 30, 2026
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
April 6, 2026
←
Previous Page
1
2
3